Latest filing published 01 Sept 2026 for NovaBridge Biosciences.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Cong Claire Xu: trading record in brief
This profile gathers the share dealings of Cong Claire Xu in NovaBridge Biosciences. The record holds 4 filings, for trades running from 4 July 2026 to 31 August 2026.
Every open-market trade on record is a sale: 2 sales worth €5,726. Besides market trades, the filings include 2 option exercises.
On 1 September 2026 came the latest disclosure, an option exercise in NovaBridge Biosciences. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cong Claire Xu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,382 sharesOrdinary SharesSEC:0002114309-26-000007:0
- 3,282 shares@ US$0.79Ordinary SharesSEC:0002114309-26-000007:1
- 12,432 sharesOrdinary SharesSEC:0002114309-26-000005:0
- 4,485 shares@ US$0.890.0017% mcap100.0% of flowOrdinary SharesSEC:0002114309-26-000005:1
4 of 4 declarations